Keywords: EFPIA, R&D-based pharma, Medicines access and affordability, Pricing

Europe’s R&D-based Pharma seeks “new dialogue” with governments on medicines access and affordability

Article | 22 June 2010

Speaking on the first day of the European Federation of Pharmaceutical Industries and Associations’ annual meeting in London, UK, yesterday, ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in